Andrew Saxon, MD
Personal Statement
My area of expertise is addiction psychiatry.
Department Affiliations
Centers/Programs
Training Programs
Scholarly Expertise
Teaching Philosophy
My training philosophy involves serving as a role model for my trainees as well as generally apply a supportive, Socratic method.
- NIDA Clinical Trials Network: Pacific Northwest Node
- Improving the implementation of smartphone-based contingency management in medical settings for the treatment of methamphetamine use disorder: a qualitative analysis of patient and clinician experiences
- Improving opioid use disorder treatment using contingency management via mHealth
- Impact of medical and recreational marijuana laws on cannabis, opioids and psychiatric medications: national study of VA patients, 2000 – 2024
- Preventing addiction related suicide
- Evaluating the Stepped Care for Opioid Use Disorder Train-the-Trainer (SCOUTT) Program
- Collaborating to Heal Addiction and Mental Health in Primary Care (CHAMP)
Recent Publications
Implementing buprenorphine for opioid use disorder in veterans health administration primary care: a qualitative analysis.
(2025 Apr 30)
Addict Sci Clin Pract 20(1): 38
Lott A, Danner AN, Malte CA, Salameh HA, Bachowski D, Gordon AJ, Hagedorn HJ, Frost MC, Williams EC, Saxon AJ, Trim RS, Hawkins EJ
(2025 Apr 30)
Addict Sci Clin Pract 20(1): 38
Lott A, Danner AN, Malte CA, Salameh HA, Bachowski D, Gordon AJ, Hagedorn HJ, Frost MC, Williams EC, Saxon AJ, Trim RS, Hawkins EJ
Experiences of Team Collaboration in Primary Care-Based Delivery of Opioid Use Disorder Treatment.
(2025 Apr 16)
J Behav Health Serv Res
Austin EJ, Bentley MJ, Ferro L, Saxon AJ, Fortney JC, Curran GM, Blanchard BE, Moghimi Y, Williams EC, Ratzliff AD, Ruiz MS, Koch U
(2025 Apr 16)
J Behav Health Serv Res
Austin EJ, Bentley MJ, Ferro L, Saxon AJ, Fortney JC, Curran GM, Blanchard BE, Moghimi Y, Williams EC, Ratzliff AD, Ruiz MS, Koch U
Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration.
(2025 Mar 26)
BMC Psychiatry 25(1): 288
Frost MC, Malte CA, Kennedy AJ, Saxon AJ, Gordon AJ, Hagedorn HJ, Williams EC, Trim RS, Lott A, Danner AN, Hawkins EJ
(2025 Mar 26)
BMC Psychiatry 25(1): 288
Frost MC, Malte CA, Kennedy AJ, Saxon AJ, Gordon AJ, Hagedorn HJ, Williams EC, Trim RS, Lott A, Danner AN, Hawkins EJ
Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients.
(2025 Apr)
Int J Drug Policy 138(): 104765
Fink DS, Samples H, Malte CA, Olfson M, Wall MM, Alschuler DM, Simpson T, Mannes Z, Saxon AJ, Hasin DS
(2025 Apr)
Int J Drug Policy 138(): 104765
Fink DS, Samples H, Malte CA, Olfson M, Wall MM, Alschuler DM, Simpson T, Mannes Z, Saxon AJ, Hasin DS
Content analysis of perceptions of combined pharmacobehavioral treatment for American Indian people with opioid use disorder.
(2025 Feb)
Psychol Addict Behav 39(1): 1-13
Nelson LA, Collins SE, Shinagawa E, Park S, Rajeev V, McPhail G, Saplan S, Taylor EM, Aguilar-Bonnette AT, Mednansky S, Douthitt J, King RJ, Taylor MA, Kominsky TK, Green C, Saxon AJ, Clifasefi SL, CHaRRM-CN Community Advisory Board
(2025 Feb)
Psychol Addict Behav 39(1): 1-13
Nelson LA, Collins SE, Shinagawa E, Park S, Rajeev V, McPhail G, Saplan S, Taylor EM, Aguilar-Bonnette AT, Mednansky S, Douthitt J, King RJ, Taylor MA, Kominsky TK, Green C, Saxon AJ, Clifasefi SL, CHaRRM-CN Community Advisory Board
Show complete publication list »
